LE
Lundbeckfonden Emerge
AcceleratorQuietLundbeckfonden Emerge is a strategic initiative of the Lundbeckfonden established in the spring of 2012.
Copenhagen, DenmarkFounded 2016
4
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lundbeckfonden Emerge.
Investment Thesis & Strategy
Lundbeckfonden Emerge, as a strategic initiative, likely invests in various stages of fintech companies, providing resources and support to accelerate their growth. They focus on identifying and nurturing promising fintech ventures.
Investment Activity
Deals per year over the last 19 years
1
20050
20060
20070
20080
20090
20101
20110
20120
20130
20140
20151
20160
20171
20181
20191
20202
20212
20221
2023Portfolio Companies
Selected investments from their portfolio of 4 companies
S
Synklino
Biotech · Seed, 2023
N
NMD Pharma A/S
Biotech · Series B, 2022
H
Hemab Therapeutics
Biotech · Series A, 2022
A
Adcendo ApS
Biotech · Series A, 2021
C
Cysbio
Biotech · Seed, 2021
H
Hoba Therapeutics
Biotech · Seed, 2020
B
Brain+ A/S
Healthcare · Growth, 2019
E
Evaxion Biotech
Biotech · Series A, 2018
O
Orphazyme
Biotech · Series B, 2016
G
Galecto
Biotech · Series A, 2011
Z
Zealand Pharma
Biotech · Growth, 2005
Frequently Asked Questions
Lundbeckfonden Emerge focuses on Pre-seed, Seed stage investments.